GlassScriptPhysician profile
David Y Josephson
NPI 1063510840
$49,329.00
in general payments reported to CMS, 2019-2025
48 companies · $3,208 in 2025
The $3,208 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $12K · 2021: $6,217 · 2022: $7,306 · 2023: $1,482 · 2024: $5,527 · 2025: $3,208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,146 · Food and Beverage: $4,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,146.19 |
| Food and Beverage | $4,070.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $23,173.26 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $10,265.68 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $3,422.02 | 2020-2025 | |
| Antares Pharma, INC. | $3,380.85 | 2019-2022 | |
| Blue Earth Diagnostics | $1,666.29 | 2019-2024 | |
| Cipla USA INC. | $674.45 | 2021 | |
| Urogen Pharma, INC. | $626.46 | 2022-2024 | Jelmyto |
| Boston Scientific Corporation | $588.16 | 2019-2024 | Lithovue |
| Dendreon Pharmaceuticals LLC | $575.52 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $539.84 | 2019-2025 | Erleada, Akeega |
| Pfizer INC. | $452.05 | 2019-2025 | |
| Astellas Pharma US INC | $426.29 | 2019-2025 | Xtandi |
| Myriad Genetic Laboratories, INC. | $377.59 | 2021-2024 | Prolaris |
| Teleflex LLC | $349.31 | 2021-2025 | Urolift, Barrigel |
| Myovant Sciences INC. | $261.14 | 2021-2022 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $244.05 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Merck Sharp & Dohme LLC | $202.14 | 2021-2024 | Keytruda, Welireg |
| Ferring Pharmaceuticals INC. | $196.93 | 2024-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $191.97 | 2021-2024 | |
| Becton, Dickinson and Company | $178.29 | 2024 | Bard Urinary Drainage Bag |
| Medtronic, INC. | $170.43 | 2023-2025 | Interstim |
| Rochester Medical Corporation | $167.55 | 2022 | |
| Sumitomo Pharma America, INC. | $132.95 | 2023-2024 | Orgovyx, Gemtesa |
| Telix Pharmaceuticals | $118.36 | 2024-2025 | Illuccix |
| C. R. Bard, INC. & Subsidiaries | $111.37 | 2023-2024 | Bard Urinary Drainage Bag |
| Profound Medical Corp. | $88.19 | 2023 | Tulsa-Pro |
| Coloplast Corp | $74.42 | 2019-2021 | |
| Edap Technomed INC | $65.81 | 2023 | |
| Photocure INC | $63.92 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $56.89 | 2021 | |
| Immunitybio, INC. | $45.32 | 2025 | |
| Abc Home Medical Supply, INC. | $41.05 | 2024-2025 | |
| Tolmar Pharmaceuticals, INC. | $40.99 | 2019-2020 | |
| Procept Biorobotics Corporation | $40.92 | 2024 | Aquabeam System |
| Bluewind Medical | $39.63 | 2024 | Revi |
| Dornier Medtech America, INC | $39.42 | 2020 | |
| Amgen INC. | $28.80 | 2019 | |
| Ethicon US, LLC | $25.78 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $24.60 | 2020 | |
| Bioprotect Medical, INC. | $23.38 | 2025 | Bioprotect Balloon Implant System |
| Axonics, INC. | $22.39 | 2022 | |
| Karl Storz Endoscopy-America | $22.33 | 2019 | |
| Palette Life Sciences, INC. | $20.81 | 2023 | |
| Urovant Sciences INC | $20.29 | 2022 | |
| Hollister Incorporated | $17.29 | 2024 | Vapro |
| Tolmar, INC. | $16.95 | 2023 | |
| Inspire Medical Systems, INC. | $16.87 | 2023 | Inspire |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Josephson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.